To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Augmented BPTB autograft performs no better than standard autograft in ACL reconstruction

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2014

Augmented BPTB autograft performs no better than standard autograft in ACL reconstruction

Vol: 3| Issue: 11| Number:73| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:1

Long-term results of a randomized study on anterior cruciate ligament reconstruction with or without a synthetic degradable augmentation device to support the autograft

Knee Surg Sports Traumatol Arthrosc. 2014 Sep;22(9):2109-20

Contributing Authors:
L Peterson U Eklund B Engstrom M Forssblad T Saartok A Valentin

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

201 patients undergoing ACL reconstruction with a single-bundle bone-patellar tendon-bone autograft were randomized to either receive or not receive an augmentation device applied to the graft. The purpose was to compare clinical and functional outcome between the two techniques. Follow-up was conducted for 4 years postoperatively, and for 12 years in a subset of patients. The results demonstrated...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue